Clinical trial
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) in Non-Diabetic Obese Patients Using Glucagon-Like Peptide-1 Receptor Agonists: A Retrospective Real-World Study
NCT07846956 is registered in ClinicalTrials.gov with Istanbul Saglik Bilimleri University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) in Non-Diabetic Obese Patients Using Glucagon-Like Peptide-1 Receptor Agonists: A Retrospective Real-World Study
- Lead sponsor
- Istanbul Saglik Bilimleri University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 21, 2026
- Completion date
- November 30, 2026
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-arteritic anterior ischemic optic neuropathy obesity, obesity